JP Morgan Chase
MDXG icon

JP Morgan Chase’s MiMedx Group MDXG Stock Holding History

JP Morgan Chase’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-82,500
Closed -$510K – 5824
2018
Q3 		$510K Buy
82,500
+35,000
+74% +$158K ﹤0.01% 4271
2018
Q2 		$304K Sell
47,500
-52,500
-53% -$374K ﹤0.01% 4389
2018
Q1 		$697K Buy
100,000
+64,400
+181% +$750K ﹤0.01% 3866
2017
Q4 		$449K Buy
+35,600
New +$434K ﹤0.01% 4112
2017
Q1 		– Sell
-76,300
Closed -$676K – 5158
2016
Q4 		$676K Buy
+76,300
New +$686K ﹤0.01% 3614

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

JP Morgan Chase's MDXG Position: Q1 2026 in Review

JP Morgan Chase reduced its MiMedx Group (MDXG) stake by 88% in Q1 2026, selling an estimated $1.72M and leaving 48,778 shares worth $188K. The position accounts for ﹤0.01% of the portfolio, ranked #5502.

JP Morgan Chase first reported a position in MDXG in Q2 2013 and has held it in 41 quarters since. The position peaked at $21M in Q3 2014. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • JP Morgan Chase held 48,778 shares of MiMedx Group worth $188K as of Q1 2026.
  • JP Morgan Chase sold 341,677 MiMedx Group shares in Q1 2026, an estimated $1.72M.
  • MiMedx Group made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5502 holding.
  • JP Morgan Chase first reported a position in MiMedx Group in Q2 2013 and has held it in 41 quarters since.
  • JP Morgan Chase's MiMedx Group position peaked at $21M in Q3 2014.
  • 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.